June 13, 2019
Meet us at the STP 2019

April, 2019
PDS joined the global SEND alliance G-SEND

February 27, 2019

Support of SENDIG 3.1

October 5, 2018
Would you like to create a SEND dataset in SENDIG 3.1 as a Pilot?

April 13, 2018
PDS Life Sciences Selects Vicente Nogués as new CEO

October 10, 2017
Specific Toxicologist/Pathologist Responses for Standard or Exchange of Nonclinical Data (SEND)

August 21, 2017
FDA Announcement: FDA CDER is announcing support for the 3.1 version of CDISC SEND IG 3.1, ending support for the 3.0 version of SEND IG, and gives update to the FDA Data Standards Catalog

June 7, 2017
BASi Announces Validated 'SEND' Capabilities and Compliance With FDA's Standard for Exchange of Nonclinical Data

May 10, 2017 
PDS Life Sciences Names New Vice President of Product Development

August 3, 2016
PDS SEND Express™ Service Selected by Global Biopharma Company

July 12, 2016
CDISC Announcement: Standard for Exchange of Nonclinical Data (SEND)

April 21, 2016
PDS Now Proven Market Leader for SEND Submissions

March 15, 2016
SENDing Data to Meet New FDA Standards
With the FDA deadline for standardized electronic data submissions approaching, the need for an effective solution for SEND dataset generation has become increasingly important. In an article on Outsourcing-Pharma.com, PDS CEO Sayed Badrawi talks about how SEND Express simplifies the complex process of implementing the SEND standard. Read the full article

March 11, 2016
PDS Life Sciences Launches SEND Express™ to Help Companies Convert Data to Meet New FDA Standards

March 4, 2016
FDA Announces Public Review of PhUSE Nonclinical SDRG Template

August 13, 2015
PDS Poster Wins AstraZeneca's !Innovation in Drug Discovery Award
Out of the 400 posters submitted at the Eurotox Annual Meeting, a poster submitted by the PDS team, FDA SEND in Non-US Countries Responses to the Standard for Exchange of Nonclinical Data (SEND) in Non-US Countries was chosen as the AstraZeneca Innovation in Drug Award Prize Winner. The PDS team who developed the poster included many members of the PDS Leadership team and will be announced on the AstraZeneca website following the meeting. Read the poster here...

August 13, 2015
CDISC Announcement: SENDIG v3.1 Draft B Now Available for Public Review

July 28, 2015
CDISC Announcement: SEND Implementation Guide for Developmental and Reproductive Toxicology Studies

July 14, 2015
BASi Announces Enhancements to the Company’s Laboratory Information Management System (LIMS)

June 19, 2015
PDS Life Sciences Becomes a Safety Alliance Partner 
PDS Life Sciences was recently selected as a Safety Alliance Partner. The Safety Alliance is managed by AnaPath GmbH, which selects a number of complementary CROs located in Europe to complete the list of partners. The alliance was built as a coordination and monitoring function for multisite studies between the different CROs in order to deliver a high-quality standard to clients. Learn more about the Safety Alliance…

May 27, 2015
Memorial Sloan Kettering Cancer Center Selects PDS Life Sciences’ Ascentos™ Software for Preclinical

March 10, 2015
PDS Life Sciences Helps Major Pharma Company Receive the First FDA Acceptance of a BLA Filing Incorporating SEND Requirements

September 16, 2014
Top 5 Pharma Company Receives FDA Validation Using TranSEND by PDS

July 15, 2014
Coupling Science with Software to Improve R&D Productivity
PDS’s CEO Sayed Badrawi was featured in July’s CIO Review Magazine. Read the full article on page 47.

May 20, 2014
PDS Releases First Publicly Available, FDA-Validated Dataset for SEND

March 21, 2014
PDS Set to Launch New Products and Branding at Society of Toxicology Annual Meeting

April 19, 2010
Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies

Membership Logo © 2017 PDS. All rights reserved.  Site Map  |  Disclaimer  |  Terms of Use Connect with us on  pds linkedin